- ICH GCP
- US Clinical Trials Registry
- Forskere
- Sverige
- Adenocarcinom
Lægespecialister fra Sverige tagget som efterforskere i kliniske forsøg, der studerer Adenocarcinom
I alt 10 resultater
-
Asif Halimi, MD/PhDSet i:
- Umeå, Surgical Clinic at Umeå University Hospital
Forsøg:- NCT05356039 (Underforsker)
- NCT05155878 (Underforsker)
Betingelser:- Livskvalitet;
- Kirurgi;
- Bugspytkirtel Adenocarcinom;
- Kemoterapi effekt;
- Bugspytkirtelkræft;
- Pancreas Neoplasma;
- Pancreas sygdom;
- Lokalt avanceret pancreas adenocarcinom;
- Borderline resektabelt bugspytkirteladenokarcinom;
- Kirurgi - Komplikationer;
- Galdevejskræft;
- Periampullær kræft;
- Bugspytkirtelfistel;
- Bugspytkirtelcyste
-
Brigitta Omazic, MD, PhDSet i:
- Stockholm, Center for allogeneic stem cell transplantation, Karolinska University hospital
Forsøg:- NCT02207985 (Ledende efterforsker)
Betingelser: -
Cecilia Radkiewicz, MD, PhDSet i:
- Stockholm, Karolinska University Hospital
Forsøg:- NCT03773367 (Ledende efterforsker)
-
Daniel Öhlund, MD/PhDSet i:
- Umeå, Surgical Clinic at Umeå University Hospital
Forsøg:- NCT05356039 (Underforsker)
- NCT05155878 (Underforsker)
Betingelser:- Livskvalitet;
- Kirurgi;
- Bugspytkirtel Adenocarcinom;
- Kemoterapi effekt;
- Bugspytkirtelkræft;
- Pancreas Neoplasma;
- Pancreas sygdom;
- Lokalt avanceret pancreas adenocarcinom;
- Borderline resektabelt bugspytkirteladenokarcinom;
- Kirurgi - Komplikationer;
- Galdevejskræft;
- Periampullær kræft;
- Bugspytkirtelfistel;
- Bugspytkirtelcyste
-
David Borg, MDSet i:
- Lund, Lund University Hospital
Forsøg:- NCT03773367 (Ledende efterforsker)
-
Jan-Erik Frödin, MDSet i:
- Stockholm, Dept. of Oncology-Pathology, Karolinska University Hospital, Solna
Forsøg:- NCT01182246 (Ledende efterforsker)
Betingelser: -
Mattias Löhr, MD, PhD,Prof.Set i:
- Stockholm, Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge
Forsøg:- NCT01182246 (Ledende efterforsker)
Betingelser: -
Oskar Franklin, MD/PhDSet i:
- Umeå, Surgical Clinic at Umeå University Hospital
Forsøg:- NCT05356039 (Ledende efterforsker)
- NCT05155878 (Ledende efterforsker)
Betingelser:- Livskvalitet;
- Kirurgi;
- Bugspytkirtel Adenocarcinom;
- Kemoterapi effekt;
- Bugspytkirtelkræft;
- Pancreas Neoplasma;
- Pancreas sygdom;
- Lokalt avanceret pancreas adenocarcinom;
- Borderline resektabelt bugspytkirteladenokarcinom;
- Kirurgi - Komplikationer;
- Galdevejskræft;
- Periampullær kræft;
- Bugspytkirtelfistel;
- Bugspytkirtelcyste
-
Stina Lindblad, MDSet i:
- Umeå, Surgical Clinic at Umeå University Hospital
Forsøg:- NCT05356039 (Underforsker)
- NCT05155878 (Underforsker)
Betingelser:- Livskvalitet;
- Kirurgi;
- Bugspytkirtel Adenocarcinom;
- Kemoterapi effekt;
- Bugspytkirtelkræft;
- Pancreas Neoplasma;
- Pancreas sygdom;
- Lokalt avanceret pancreas adenocarcinom;
- Borderline resektabelt bugspytkirteladenokarcinom;
- Kirurgi - Komplikationer;
- Galdevejskræft;
- Periampullær kræft;
- Bugspytkirtelfistel;
- Bugspytkirtelcyste
-
Ulrika Pallenius, MDSet i:
- Växjö, Centrallasarettet i Växjö
Forsøg:- NCT03773367 (Ledende efterforsker)
Kliniske forsøg med Adenocarcinom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeKlinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk trin IV Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Uoperabelt Gastroøsofageal Junction Adenocarcinoma | Lokalt avanceret Gastroøsofageal Junction Adenocarcinoma | Postneoadjuverende terapi Stage III Gastroøsofageal... og andre forholdForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeEsophageal Adenocarcinom | Esophageal pladecellekarcinom | Klinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk fase II Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk fase IVA Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Patologisk trin IIIA Gastroøsofageal... og andre forholdForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetGastroøsofageal Junction Adenocarcinom | Stadie IB Esophageal Adenocarcinoma AJCC v7 | Stadie II Esophageal Adenocarcinoma AJCC v7 | Stadie IIA Esophageal Adenocarcinoma AJCC v7 | Stadie IIB Esophageal Adenocarcinoma AJCC v7 | Stadie IIIA Esophageal Adenocarcinoma AJCC v7 | Stadie IIIB Esophageal...Forenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeGastrisk Adenocarcinom | Klinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk fase 0 Mavekræft AJCC v8 | Klinisk fase I gastrisk cancer AJCC v8 | Klinisk fase IIB gastrisk cancer AJCC v8 | Klinisk fase IVA gastrisk cancer AJCC v8 | Patologisk fase 0 Mavekræft AJCC v8 | Patologisk... og andre forholdForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)AfsluttetKlinisk fase IV gastrisk cancer AJCC v8 | Klinisk trin IV Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Metastatisk gastrisk adenocarcinom | Metastatisk Gastroøsofageal Junction Adenocarcinoma | Postneoadjuverende terapi Stage IV Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Postneoadjuverende... og andre forholdForenede Stater
-
M.D. Anderson Cancer CenterRekrutteringKlinisk fase III gastrisk cancer AJCC v8 | Klinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk fase IV gastrisk cancer AJCC v8 | Klinisk trin IV Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Metastatisk gastrisk adenocarcinom | Metastatisk Gastroøsofageal Junction Adenocarcinoma og andre forholdForenede Stater
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RekrutteringKlinisk fase III gastrisk cancer AJCC v8 | Klinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk fase IV gastrisk cancer AJCC v8 | Klinisk trin IV Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Metastatisk gastrisk adenocarcinom | Metastatisk Gastroøsofageal Junction Adenocarcinoma og andre forholdForenede Stater
-
NRG OncologyNational Cancer Institute (NCI)RekrutteringKlinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Uoperabelt Gastroøsofageal Junction Adenocarcinoma | Postneoadjuverende terapi Stage III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Postneoadjuverende terapi trin IIIA Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Postneoadjuverende... og andre forholdForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringKlinisk trin III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk fase II esophageal adenokarcinom AJCC v8 | Klinisk fase IIA Esophageal Adenocarcinoma AJCC v8 | Klinisk trin III esophagealt adenokarcinom AJCC v8 | Patologisk stadie IB Esophageal Adenocarcinom AJCC v8 | Patologisk stadium... og andre forholdForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendePeritoneal karcinomatose | Klinisk fase IV gastrisk cancer AJCC v8 | Klinisk trin IV Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Metastatisk gastrisk adenocarcinom | Metastatisk Gastroøsofageal Junction Adenocarcinoma | Postneoadjuverende terapi Stage IV Gastroøsofageal Junction Adenocarcinoma... og andre forholdForenede Stater